|
|
Cerebrovasc Dis. Author manuscript; available in PMC 2009 March 30. Published in final edited form as: Published online 2008 September 18. doi: 10.1159/000155637. | PMCID: PMC2662496 NIHMSID: NIHMS92655 |
Single nucleotide polymorphisms associated with coronary heart disease predict incident ischemic stroke in the Atherosclerosis Risk in Communities (ARIC) study Alanna C. Morrison, PhD,1 Lance A. Bare, PhD,2 May M. Luke, PhD,2 James S. Pankow, PhD,3 Thomas H. Mosley, PhD,4 James J. Devlin, PhD,2 James T. Willerson, MD,5 and Eric Boerwinkle, PhD1,6 1Human Genetics Center and Division of Epidemiology; University of Texas Health Science Center at Houston; 1200 Herman Pressler; Suite 453E; Houston, TX 77030 2Celera; 1401 Harbor Bay Parkway; Alameda, CA 94502 3Division of Epidemiology and Community Health; University of Minnesota; 1300 South Second Street, Suite 300; Minneapolis, MN 55454-1015 4University of Mississippi Medical Center; Department of Medicine (Geriatrics); 2500 N. State Street, Room 204; Jackson, MS 39216-4505 5 Texas Heart Institute; 6770 Bertner; Suite C550J; Houston, TX 77030 6 Institute of Molecular Medicine; University of Texas Health Science Center at Houston; 1825 Herman Pressler; Houston, TX 77030 Ischemic stroke and coronary heart disease (CHD) may share genetic factors contributing to a common etiology. This study investigates whether 51 single nucleotide polymorphisms (SNPs) associated with CHD in multiple antecedent studies are associated with incident ischemic stroke in the Atherosclerosis Risk in Communities (ARIC) study. From the multi-ethnic ARIC cohort of 14,215 individuals, 495 validated ischemic strokes were identified. Cox proportional hazards models, adjusted for age and gender, identified three SNPs in Whites and two SNPs in Blacks associated with incident stroke (p≤0.05). The rs11628722 polymorphism in SERPINA9 was associated with incident stroke in Whites and Blacks, even after taking into account traditional risk factors. The idea that ischemic stroke and CHD may share some common genetic factors, such as variation in SERPINA9, should be investigated in other studies. Keywords: genetics, stroke, ischemic, myocardial infarction, polymorphism In the United States, cardiovascular disease is the leading cause of death.[ 1] Coronary heart disease (CHD) and stroke, respectively, represent the first and third most common causes of mortality and morbidity.[ 1] Although these diseases involve different vascular beds, at least a portion of CHD and ischemic stroke cases are known to be the result of atherosclerotic disease and its complications.[ 2] The idea that stoke and CHD share some predisposing pathologies is supported by the fact that these diseases share risk factors, such as age, gender, smoking, diabetes and hypertension.[ 2] These and other traditional risk factors have been incorporated into risk prediction models for CHD and stroke.[ 3, 4] Shared risk factors for these diseases may also encompass genetic factors, such as gene variants involved in atherosclerosis. Recently, risk prediction models for CHD were improved by incorporating a genetic risk score that aggregates the contribution of multiple single nucleotide polymorphisms (SNPs).[ 5] Given the shared atherosclerotic pathology between CHD and stroke and the possible involvement of common genetic risk factors, 51 putative functional SNPs that had been found to be associated with CHD in multiple studies [ 5, 6] were evaluated for their ability to predict incident ischemic stroke in the Atherosclerosis Risk in Communities (ARIC) Study. These SNPs were further investigated for their ability to predict ischemic stroke independent of established risk factors. The Atherosclerosis Risk in Communities (ARIC) Study Study participants were selected from the ARIC Study, a prospective investigation of atherosclerosis and its clinical sequelae involving 15,792 individuals aged 45-64 years at recruitment (1986-1989). Subjects were selected by probability sampling from four communities: Forsyth County, NC; Jackson, MS (Blacks only); Northwestern suburbs of Minneapolis, MN; and Washington County, MD. The initial clinical exams included a home interview to ascertain cardiovascular risk factors, socioeconomic factors and family medical history, clinical examination and blood drawing for laboratory determinations. A detailed description of the ARIC study design and methods has been published elsewhere.[ 7] Incident Ischemic Stroke Ischemic stroke was determined by contacting participants annually to identify hospitalizations during the previous year, and by surveying discharge lists from local hospitals and death certificates from state vital statistics offices for potential cerebrovascular events.[ 7, 8] Hospital records were obtained, abstracted and classified by computer algorithm and physician review. Details on quality assurance for ascertainment and classification of ischemic stroke events have been published elsewhere.[ 8] Ischemic stroke events were defined as validated definite or probable hospitalized embolic (N=87) or thrombotic (N=408) brain infarctions. Participants were excluded from this analysis if they had a positive or unknown history of prevalent stroke; transient ischemic attack/stroke symptoms or CHD at the initial visit; ethnic background other than White or Black; an ethnic background of Black but were not from Jackson, MS; restrictions on use of their DNA; or missing data for any of the traditional cardiovascular or cerebrovascular risk factors. The remaining 14,215 participants were followed for incident ischemic stroke for a mean of 13.5 years and 495 incident ischemic stroke cases were identified. Examination and Laboratory Measures Cardiovascular risk factors considered in this study were measured at baseline and included age, gender, waist-to-hip ratio, diabetes, hypertension, and smoking status. The ratio of waist (umbilical level) and hip (maximum buttocks) circumference was calculated as a measure of fat distribution. Diabetes was defined by a fasting glucose level ≥126 mg/dl, a nonfasting glucose level ≥200 mg/dl, or a self-reported physician diagnosis of diabetes or use of diabetes medication. Seated blood pressure was measured three times with a random-zero sphygmomanometer and the last two measurements were averaged. An interviewer-administered questionnaire was used to assess use of antihypertensive medications. Hypertension was defined as systolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg or current use of antihypertensive medication. Cigarette smoking status was classified as current or not current. The study protocol was approved by the Institutional Review Boards of the collaborating institutions, and informed written consent was obtained from each participant. SNP Selection and Genotype Determination Fifty-one putative functional SNPs associated with CHD in multiple antecedent studies, other than the ARIC study, were considered in this study. A detailed description of the antecedent studies is presented elsewhere.[ 6] Briefly, risk alleles for 49 SNPs were specified based on significant association with myocardial infarction in at least two antecedent case-control studies. These studies involved myocardial infarction cases and controls recruited by either the Cleveland Clinic Foundation Heart Center, Cleveland, Ohio (CCF) or the Genomic Resource in Arteriosclerosis at the University of California, San Francisco (UCSF). All cases in these two studies had a history of myocardial infarction and the controls did not, and all subjects were self–described, non-Hispanic Caucasians. The risk alleles for two additional SNPs were specified based on an association with CHD in the placebo arms of two CHD prevention trials: the Cholesterol and Recurrent Events (CARE) study [ 9] and the West of Scotland Coronary Prevention Study (WOSCOPS).[ 10] One of these SNPs (rs20455 in KIF6) was significantly associated with CHD after correction for multiple testing.[ 11]. The second SNP associated with CHD in CARE and WOSCOPS was rs11666735 in FCAR.[ 12] Genotyping of the 51 SNPs in the ARIC study was carried out using PCR-based amplification of genomic DNA followed by an allele specific oligonucleotide ligation assay similar to a previously described procedure.[ 13] The primer sequences for genotyping these 51 SNPs are available from the authors upon request. Statistical Analyses Agreement of genotype frequencies with Hardy-Weinberg equilibrium expectations was tested separately in Whites and Blacks using a χ 2 goodness-of-fit test in non-cases, stratified by ethnicity. Deviation from Hardy-Weinberg equilibrium was determined by a p-value less than 0.05. Cox proportional hazards models were used to model time to incident ischemic stroke. The follow-up time interval was defined as the time between the initial clinical visit and the end of follow-up, which for cases was the date of the first ischemic stroke event and for non-cases was December 31, 2002, the date of death, or the date of last contact if lost to follow-up. Each model was evaluated separately in Whites and Blacks and included a given SNP (modeled as the additive effect of the pre-specified risk allele), age and gender. Additional risk factors evaluated as potential confounders in the Cox proportional hazards models included waist-to-hip ratio, diabetes, hypertension, and smoking status.[ 14] SNPs and risk factors were assessed for statistical significance in the models by the Wald statistic. A two-sided p-value of 0.05 was used to assess statistical significance with ischemic stroke and no attempt was made to adjust for multiple comparisons within this study. Race-specific proportions, means and standard deviations for the traditional risk factors are presented in Table 1. Mean values and proportions differed significantly (p≤0.03) between incident ischemic stroke cases and non-cases for all risk factors. The results from the Cox proportional hazards models, adjusting for age and gender, for all 51 SNPs are detailed in Appendix 1 (online supplement). Results are not reported for three SNPs in Whites and four SNPs in Blacks because the genotype frequencies deviated from Hardy-Weinberg expectations. Three SNPs in Whites (in SERPINA9, PALLD and IER2) and two SNPs in Blacks (in SERPINA9 and EXOD1) were associated (p≤0.05) with ischemic stroke, after adjusting for age and gender, and had the same risk allele as specified by the antecedent studies ( Table 2, Model 1). One additional SNP in EIF2AK2 was associated with ischemic stroke in Whites, but the risk allele in the ARIC study differed from the risk allele identified in the antecedent CHD studies. The rs11628722 polymorphism in SERPINA9 was associated with incident ischemic stroke in both ethnicities (Whites HRR=1.31, 95% CI: 1.00-1.70; Blacks HRR=1.26, 95% CI: 1.03-1.53). | Table 2SNPs Associated with Incident Ischemic Stroke in the ARIC Study |
For the four SNPs that were associated in either ethnic group, traditional cardiovascular risk factors were included in the Cox proportional hazards models to evaluate possible confounding. The observed hazards ratios were essentially unchanged with addition of these risk factors to the prediction models ( Table 2, Model 2). This study investigated whether 51 putative functional SNPs associated with CHD in multiple antecedent studies predict ischemic stroke among White and Black individuals from the large prospective ARIC study. The motivation for this study comes from the fact that ischemic stroke and CHD may share genetic factors. Three SNPs in Whites and two SNPs in Blacks were associated with incident ischemic stroke, even after taking into account established risk factors. The rs11628722 polymorphism in SERPINA9 was associated with ischemic stroke in both Whites and Blacks from the ARIC study. Few of the 51 SNPs that had been previously associated with CHD were associated with incident stroke in ARIC, and none of them would have been significantly associated with stroke after a simple Bonferroni multiple testing correction for the 51 SNPs tested. These results may be due to the fact that SNPs that confer only modest risk may not replicate in every study, or ischemic stroke and CHD may not have these genetic factors in common. However, it is noteworthy that the association between SERPINA9 and stroke was observed in both Whites and Blacks in this study. This SNP has been associated with myocardial infarction in two case-control studies and this study shows an association with stroke in both Whites and Blacks from the ARIC study. SERPINA9 is a member of clade A of the large superfamily of serine peptidase inhibitors known as serpins. Serpins are protease inhibitors that use a conformational change to inhibit target enzymes, and are involved in many cellular processes, such as coagulation, fibrinolysis, complement fixation, matrix remodeling and apoptosis.[ 15] Little is known about the expression of SERPINA9; however, a recent study indicated that SERPINA9 was significantly upregulated in the hippocampal tissues from Alzheimer's disease transgenic mice versus age-matched controls.[ 16] This study suggests that SERPINA9 may also be expressed in the human brain, consistent with our observation of an association between polymorphic variation in this gene and ischemic stroke. In addition to SERPINA9, polymorphisms in palladin ( PALLD) and immediate early response 2 ( IER2) were associated with ischemic stroke in Whites and a polymorphism in exonuclease domain containing 1 ( EXOD1) was associated in Blacks. PALLD encodes a component of the cytoskeleton that controls cell shape and motility. Vascular remodeling may lead to atherosclerosis, and the shape and cytoskeletal organization of endothelial cells is an important part of this process. Mechanical stress and strain also plays a role in atherosclerotic vascular remodeling and immediate early response genes have been shown to mediate the mechanical stress-induced pathological process in the blood vessel.[ 17] Although little is known about EXOD1, exonucleases have been shown to play a role in both myocardial infarction and stroke. Given their functional roles, PALLD, IER2 and EXOD1 potentially play a role in the atherosclerotic pathway. Additionally, PALLD, IER2 and EXOD1 are all expressed in the heart and brain ( www.genecards.org). A strength of this study is the prospective cohort design which is “valuable for critically examining the potential risk factors that are initially identified through other approaches, including case-control studies.”[ 18] The large sample size allows for the assessment of exposures (e.g. genetic factors) of modest effect. All analyses for this study were performed separately in Whites and Blacks; however, it is important to note that ethnicity in the ARIC study is self-reported and underlying population stratification may be a potential limitation. In summary, we have identified genes associated with incident ischemic stroke in the ARIC study. In particular, SERPINA9 was associated with stroke in both Whites and Blacks and this association does not appear to be mediated by traditional risk factors. This study underscores the utility of large-scale genomic studies of the occurrence of stroke in humans in order to identify and localize stroke susceptibility genes. The Atherosclerosis Risk in Communities (ARIC) study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, and N01-HC-55022. The authors thank the staff and participants of the ARIC study for their important contributions. 1. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2007 Update. Circulation. 2007;115:e69–e171. [PubMed] 2. Duvall W, Vorchheimer D. Multi-bed vascular disease and atherothrombosis: scope of the problem. Journal of Thrombosis and Thrombolysis. 2004;17(1):51–61. [PubMed] 3. Wilson P, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837–1847. [PubMed] 4. Wolf P, et al. Probability of stroke: a risk profile from the Framingham study. Stroke. 1991;22(3):312–318. [PubMed] 5. Morrison A, et al. Coronary heart disease risk prediction using a genetic risk score: the Atherosclerosis Risk in Communities (ARIC) Study. American Journal of Epidemiology. 2007;166(1):28–35. [PubMed] 6. Bare L, et al. Five common gene variants identify elevated genetic risk for coronary heart disease. Genetics in Medicine. 2007 In press. 7. ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. American Journal of Epidemiology. 1989;129:687–702. [PubMed] 8. Rosamond W, et al. Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke. 1999;30:736–743. [PubMed] 9. Sacks F, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels Cholesterol and Recurrent Events Trial Investigators. New England Journal of Medicine. 1996;335(14):1001–1009. [PubMed] 10. Packard C, et al. Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease West of Scotland Coronary Prevention Study Group. New England Journal of Medicine. 2000;343(16):1148–1155. [PubMed] 11. Iakoubova O, et al. Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in two prospective studies: The Cholesterol and Recurrent Events Study (CARE) and the West of Scotland Coronary Prevention Study (WOSCOPS). Journal of the American College of Cardiology. 2007 Unpublished data. 12. Iakoubova O, et al. Asp92Asn polymorphism in the myeloid IgA Fc receptor is associated with myocardial infarction in two disparate populations: CARE and WOSCOPS. Arteriosclerosis, Thrombosis and Vascular Biology. 2006;26(12):2763–2768. 13. Iannone M, et al. Multiplexed single nucleotide polymorphism genotyping by oligonucleotide ligation and flow cytometry. Cytometry. 2000;39(2):131–140. [PubMed] 14. Folsom A, et al. Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. Diabetes Care. 1999;22:1077–1083. [PubMed] 15. Law R, et al. An overview of the serpin superfamily. Genome Biology. 2006;7(5):216. [PubMed] 16. Jee S, et al. Oligonucleotide-based analysis of differentially expressed genes in hippocampus of transgenic mice expressing NSE-controlled APPsw. Neurochemistry Research. 2006;31:1035–1044. 17. Liu S. Biomechanical basis of vascular tissue engineering. Critical Reviews in Biomedical Engineering. 1999;27:75–148. [PubMed] 18. Manolio T, Bailey-Wilson J, Collins F. Genes, environment and the value of prospective cohort studies. Nature Reviews Genetics. 2006;7(10):812–820.
|
The publisher's final edited version of this article is available at 